GRF presents Catalyst, Visionary Awards to leaders in medicine, science
February 5th 2015Glaucoma Research Foundation (GRF) honored a long-time global leader in ophthalmology with its Catalyst Award on Thursday night at the foundation’s Glaucoma 360 Annual Gala and presented two renowned stem-cell researchers with its Visionary Award.
Questions remain if anti-VEGF therapy influences atrophy in neovascular AMD
February 3rd 2015Analysis of the Harbor Study data could not definitively answer the question about whether anti-vascular endothelial growth factor (VEGF) therapies influence the development of atrophy in patients with neovascular age-related macular degeneration (AMD). However, investigators did find that the visual acuity (VA) continued to improve in patients treated with monthly and as-needed drug regimens and that certain risk factors can predict development of atrophy, according to Srinivas Sadda, MD.
Electrophysiology's role in early detection of glaucoma
February 1st 2015An office-based system (NOVA Testing System, Diopsys) represents an advance in electrophysiological technology that allows clinicians the ability to detect pathology they have been unable to see in the past, thereby detecting disease early.
What patients are saying about your office
February 1st 2015How does a practice remedy a long waiting time for patients? First, you must be concerned and communicate it to the staff. Physicians should watch or “visit” the reception area periodically to see if there is a “crowd.” Look at the patient’s scheduled time and monitor this regularly. Of course, the physician also should get to the office a little early and be ready to see the first patient when he/she is ready.
Strategies for surgical intervention aid in peripheral corneal disease
February 1st 2015Peripheral melting disorders require surgical intervention when all else has failed and there is an impending risk of perforation. A peripheral C- or banana-shaped graft can restore tectonic integrity while maintaining a reasonable corneal contour to preserve vision.
Predicting glaucoma onset: AIG identifies prognostic value for FD-OCT
February 1st 2015Analyses of data from the Advanced Imaging for Glaucoma Study showed many Fourier-domain optical coherence tomography parameters were significant risk factors for glaucoma onset in eyes that were glaucoma suspect or had pre-perimetric glaucoma.
Laser-assisted procedure brings ease, precision, safety to deep sclerectomy
February 1st 2015CO2 laser-assisted sclerectomy surgery performed with a proprietary platform offers an effective and safer alternative to manual non-penetrating deep sclerectomy procedure for the management of medically uncontrolled open-angle glaucoma.
Computer-guided treatment delivery builds on benefits of SLT
February 1st 2015Pattern scanning laser trabeculoplasty uses computer guidance for precise delivery of laser spots to the trabecular meshwork. At 6 months post-treatment, percentage IOP reduction was similar in eyes undergoing PSLT performed with a 577-nm laser compared with selective laser trabeculoplasty using a 532-nm laser.
What dying wishes or regrets might ophthalmologists have?
February 1st 2015When faced with a particularly difficult decision, Alastair Mitchell Mitchell uses the “big red bus test.” He thinks about walking out of his building in London and crossing the street, only to turn and see that one of those monstrous London double-decker red buses is literally about to flatten him and send him to the hereafter. In the brief instant before the bus hits him, he wonders what would be the thing that he would most regret not having accomplished. The answer to this question should guide prioritization of the efforts of a successful chief executive officer, businessman, or (presumably) ophthalmologist.
Subretinal fluid protective of vision, CATT study finds
February 1st 2015Subretinal fluid was associated with better visual acuity, whereas greater thickness of the subretinal tissue complex was associated with worse visual acuity in the second year of the Comparison of Age-related Macular Degeneration Treatment Trials.
Adherence, persistence of glaucoma drug superior among prior latanoprost users
February 1st 2015Adherence and persistence among patients prescribed bimatoprost 0.03% or bimatoprost 0.01% was investigated using pharmacy claims data, and the results showed statistically significant differences favoring bimatoprost 0.01%.
Microbypass trabecular stent delivers significant, durable efficacy
February 1st 2015Follow-up to 3 years in a study of eyes undergoing combination cataract surgery with implantation of a single microbypass trabecular stent shows a 36% reduction from baseline mean medicated IOP and 84% reduction in daily medication use.
Brinzolamide/brimonidine demonstrates broad efficacy in subgroup analyses
February 1st 2015The protocols for the pivotal trials establishing the efficacy of the brinzolamide 1%/brimonidine 0.2% fixed combination included pre-planned analyses of subgroups defined by IOP and demographic characteristics.
Joel Schuman, MD, discusses Glaucoma 360 and the Catalyst for a Cure
January 31st 2015Joel Schuman, MD, FACS, director of the UPMC Eye Center at the University of Pittsburgh, discusses the upcoming Glaucoma 360 meeting and the Catalyst for a Cure. The meeting is planned for Feb. 5-7 in San Francisco. Both programs are part of Glaucoma Research Foundation's mission to prevent vision loss from glaucoma by investing in innovative research.
Interim study results favor femtosecond laser astigmatic keratotomy procedure
January 27th 2015Preliminary results from a single center phase IV study support the safety and efficacy of femtosecond laser astigmatic keratotomy in patients undergoing cataract surgery or refractive lens exchange, said Pavel Stodulka, MD, PhD.
Study: complementary, alternative meds for glaucoma show no benefit, harm
January 20th 2015Complementary and alternative medicine (CAM) is a multibillion-dollar industry in the United States, and the fact that it lacks regulatory oversight creates some cause for concern. However, when it comes to glaucoma, it appears that CAM use is modest and mostly benign, but also backed by little evidence of efficacy, said Derek S. Welsbie, MD, PhD.
Expert hints: 7 ways to avoid HIPAA violations via social media
January 17th 2015These days, social media is king. Everything has become shareable and information can be passed along with just a click of a post or tweet button. But what happens if someone posts their negative feelings about your clinic, your staff, or even you online for the world to see? What if a patient desperately needs answers to their eye issue and reaches out to you via Facebook or Twitter for an answer? These scenarios can quickly turn into violations of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) if handled incorrectly.In this Q&A with Misti Buard, a certified marketing coach, we delve into everything physicians need to know to prevent HIPAA violations via social media.